Back to Results
First PageMeta Content
Pharmacology / Xylometazoline / Chemistry / Nasal spray / Topical decongestants / Medicine / Imidazolines


Microsoft Word - PAR_1763_MR_xylometazoline_2 July 2010.doc
Add to Reading List

Document Date: 2013-03-15 10:40:34

Open Document

File Size: 94,48 KB

Share Result on Facebook

Company

Novartis / Sandoz B.V. / /

Country

United States / Netherlands / /

Event

FDA Phase / /

IndustryTerm

production site / reference medicinal product / pharmaceutical ingredient / i.e. healthcare professionals / pharmaceutical development / clear and colourless solutions / healthcare professionals / chemical-pharmaceutical quality / xylometazoline products / pharmaceutical ingredients / drug product / nasal solution / reference product / validation protocol / authorized reference medicinal product / medicinal product / reference products / identical products / human medicinal products / manufacturing / mg/ml nasal spray product / mg/ml products / drug products / generic products / medicinal products / xylometazoline containing products / Manufacturing process / /

MedicalCondition

nasal congestion / rhinitis / CMD / diseases / sinusitis / /

Organization

Medicines Evaluation Board / European Pharmacopoeia Committee for Medicinal Products / European Union / European Drug Master File European Directorate for the Quality of Medicines European Union Good Clinical Practice Good Laboratory Practice Good Manufacturing Practice International Conference / /

Product

sodium chloride / disodium edetate / Nikon D50 Digital Camera / Xylometazoline / /

ProgrammingLanguage

EC / /

Technology

alpha / validation protocol / /

SocialTag